Reply: Comment on ‘A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients’

被引：0
|
作者：
J Szkandera
M Pichler
M Stotz
A Gerger
机构：
[1] Medical University of Graz,Division of Clinical Oncology, Department of Medicine
来源：
British Journal of Cancer | 2013年 / 109卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3126 / 3127
页数：1
相关论文
共 50 条
  • [1] Reply: Comment on 'A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients'
    Szkandera, J.
    Pichler, M.
    Stotz, M.
    Gerger, A.
    BRITISH JOURNAL OF CANCER, 2013, 109 (12) : 3126 - 3127
  • [2] A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
    G Absenger
    J Szkandera
    M Pichler
    M Stotz
    F Arminger
    M Weissmueller
    R Schaberl-Moser
    H Samonigg
    T Stojakovic
    A Gerger
    British Journal of Cancer, 2013, 109 : 395 - 400
  • [3] A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
    Absenger, G.
    Szkandera, J.
    Pichler, M.
    Stotz, M.
    Arminger, F.
    Weissmueller, M.
    Schaberl-Moser, R.
    Samonigg, H.
    Stojakovic, T.
    Gerger, A.
    BRITISH JOURNAL OF CANCER, 2013, 109 (02) : 395 - 400
  • [4] Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Clinical Outcome in Patients with Stage II and III Colon Cancer
    Absenger, Gudrun
    Szkandera, Joanna
    Stotz, Michael
    Postlmayr, Ulrich
    Pichler, Martin
    Ress, Anna Lena
    Schaberl-Moser, Renate
    Loibner, Hans
    Samonigg, Hellmut
    Gerger, Armin
    ANTICANCER RESEARCH, 2013, 33 (10) : 4591 - 4594
  • [5] The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
    M Stotz
    M Pichler
    G Absenger
    J Szkandera
    F Arminger
    R Schaberl-Moser
    H Samonigg
    T Stojakovic
    A Gerger
    British Journal of Cancer, 2014, 110 : 435 - 440
  • [6] The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
    Stotz, M.
    Pichler, M.
    Absenger, G.
    Szkandera, J.
    Arminger, F.
    Schaberl-Moser, R.
    Samonigg, H.
    Stojakovic, T.
    Gerger, A.
    BRITISH JOURNAL OF CANCER, 2014, 110 (02) : 435 - 440
  • [7] AN ELEVATED NEUTROPHIL/LYMPHOCYTE RATIO PREDICTS WORSE OUTCOME IN RESECTED STAGE II COLON CANCER
    Urrejola, G.
    Bambs, C.
    Espinoza, M.
    Zuniga, A.
    Campbell, J.
    Niklitschek, S.
    Pulgar, D.
    Pinedo, G.
    DISEASES OF THE COLON & RECTUM, 2010, 53 (04) : 649 - 649
  • [8] Prediction of oncologic outcome using systemic neutrophil-to-lymphocyte ratio in stage II and III colon cancer
    Park, Y.
    Lee, K.
    Lee, J.
    Oh, S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [9] The preoperative neutrophil to lymphocyte ratio predicts disease-free survival and overall survival in patients with stage II and III colon cancer
    Absenger, G.
    Szkandera, J.
    Weissmueller, M.
    Postlmayr, U.
    Pichler, M.
    Loibner, H.
    Samonigg, H. S.
    Gerger, A.
    ONKOLOGIE, 2012, 35 : 55 - 56
  • [10] The dynamic change of neutrophil to lymphocyte ratio can predict clinical outcome in stage I-III colon cancer
    Li, Zhigui
    Zhao, Rui
    Cui, Yaping
    Zhou, Yong
    Wu, Xiaoting
    SCIENTIFIC REPORTS, 2018, 8
12345